This finding was underlined by reduced activation of CD4+ and CD8+ T cells, assessed by CD69 co-staining, in CD28SA-treated hαSyn PD mice compared to PBS vehicle-injected hαSyn PD controls to comparable levels as found in both EV groups (Fig. 6A–D). This evidence concerns the gene CD8A and Parkinson disease.